Financials data is unavailable for this security.
View more
Year on year Celularity Inc had net income deteriorate from a gain of 14.19m to a loss of 196.30m despite revenues that grew 26.68% from 17.98m to 22.77m over the same period.
| Gross margin | 29.66% |
|---|---|
| Net profit margin | -862.04% |
| Operating margin | -950.54% |
| Return on assets | -72.04% |
|---|---|
| Return on equity | -163.67% |
| Return on investment | -94.47% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Celularity Inc fell by 18.64m. Cash Flow from Financing totalled 24.09m or 105.81% of revenues. In addition the company used 38.69m for operations while cash used for investing totalled 4.05m.
| Cash flow per share | -10.71 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 2.11 |
|---|---|
| Tangible book value per share | 1.17 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.2941 |
|---|---|
| Quick ratio | 0.2086 |
| Total debt/total equity | 0.958 |
|---|---|
| Total debt/total capital | 0.4893 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items dropped -1,263.39%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -40,728.95 |
